Broadhurst Vanessa 4

What Happened
Vanessa Broadhurst, a director of Zoetis Inc. (ZTS), received a grant of 1,936 restricted stock units (reported as a derivative award) on February 18, 2026. The units were reported at $0.00 per share (standard for RSU grants) and are contingent rights to receive common stock if vesting conditions are met.

Key Details

• Transaction type: Award/Grant (Form 4 code A — RSUs, derivative security)
• Grant date: February 18, 2026; Filing date: February 19, 2026 (filed the day after the transaction)
• Shares/units granted: 1,936 RSUs; reported acquisition price: $0.00
• Shares owned after transaction: Not disclosed in this filing
• Footnotes of note:
  • F1–F2: These are RSUs under Zoetis’s equity plan; each RSU equals a contingent right to one share and includes dividend equivalent units.
  • F3/F5: The filing states each RSU will vest and be settled in shares on the first anniversary of the grant (filing lists relevant anniversary dates); vesting is subject to continued service and certain events.
• No indication of tax withholding, cashless exercise, 10b5-1 plan, or late filing in the report.

Context
RSU grants are compensation awards, not open-market purchases or sales. They do not immediately change the company’s outstanding shares until they vest and are settled into stock; they also do not by themselves indicate an insider is buying or selling stock for market-confidence reasons. For investors, RSU grants are routine director/executive compensation; monitor future Form 4s for any subsequent sales after vesting.